logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-c-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

Anita Gadhok Strengthens MORSE Consulting’s Payer Expertise

October 9, 2018
-
Market Access News, What's New
-
Posted by MORSE Team - < 1 min read.

Toronto, October 9, 2018 –MORSE Consulting is pleased to announce the addition of Anita Gadhok as Senior Consultant.

With more than 20 years of experience, Anita has worked with provincial drug programs, cancer agencies, private insurance, and community pharmacies in both Ontario and Manitoba. She has been involved in a number of ground-breaking initiatives including precursor work to support the development of the pan-Canadian Oncology Drug Review (pCODR), evaluation framework for drugs for rare diseases (DRDs), as well as playing an active role in the development and operations of the pan-Canadian Pharmaceutical Alliance (pCPA). She has a depth of experience in negotiations, having participated in over 100 pCPA files (including having lead/co-lead 10 negotiations), and a further 100+ Ontario specific product listing agreements (PLAs).

Anita brings a discerning and comprehensive perspective of the public and private reimbursement markets as well as practical health system level experience. Her background in public/private sectors, cancer agencies, and pharmacy practice, provides a unique and broad outlook to help develop innovative solutions and positions her well to provide meaningful advice to clients to help them navigate through an increasingly complex and dynamic reimbursement landscape.

As Senior Consultant, Anita will contribute to our clients’ success by providing critical payer insights through MORSE’s market access, reimbursement, health policy and negotiation strategy services.

Share
Tags
DRD
Drugs For Rare Diseases
Market Access Strategy
MORSE Team
Negotiation Strategy
pCPA
PLA
Public Payers
Reimbursement strategy
Stakeholder strategy
← PREVIOUS POST
pCPA Reducing Time to Initiate Negotiations
NEXT POST →
PMPRB Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

Contact Us
MORSE Consulting Inc.
Toronto | Ottawa, Canada
+1-647-717-3179 (Toronto)
+1-613-864-8645 (Ottawa)
info@morseconsulting.ca
Social
Connect & Follow:

New Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2021 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
Anita Gadhok Strengthens MORSE Consulting’s Payer Expertise
Private
Public
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB

Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Public
Private
Public
INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB
Private

INESSS
CADTH

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

PMPRB